Genomic Valley Biotech Market Cap ($988,889 USD)
Genomic Valley Biotech Market Cap ($988,889 USD). As of Oct. 5, 2026, Genomic Valley Biotech (GVBL) market capitalisation is ₹8.90 Cr ($988,889), with 30.43 L shares outstanding at a current price of ₹29.25 on BSE, ranking 4964 out of 5368 companies by market cap in our screener. Genomic Valley Biotech operates in the Healthcare sector and is classified as a Small Cap stock. For live price, earnings and the complete company profile, see GVBL stock price BSE.
Market Cap History of Genomic Valley Biotech (Last 10 Years)
GVBL market capitalisation from year-end BSE closing prices over the last 10 years. Compare with Genomic Valley Biotech value estimation to assess whether the stock is under or overvalued.
End of Year Market Cap History — Genomic Valley Biotech
GVBL year-end market cap in INR and USD with closing share price and annual change — BSE closing prices. Review GVBL earnings multiple to evaluate earnings-based valuation against sector peers.
| Year | Market Cap | Share Price | Exchange | Change |
|---|---|---|---|---|
| 2026 |
₹8.90 Cr
$988,889 USD
|
₹29.25 | BSE | +18.37% |
| 2025 |
₹7.52 Cr
$835,400 USD
|
₹24.71 | BSE | -69.09% |
| 2024 |
₹24.33 Cr
$2.70M USD
|
₹79.95 | BSE | +113.54% |
| 2023 |
₹11.39 Cr
$1.27M USD
|
₹37.44 | BSE | +55.68% |
| 2022 |
₹7.32 Cr
$813,086 USD
|
₹24.05 | BSE | +6.89% |
| 2021 |
₹6.85 Cr
$760,684 USD
|
₹22.50 | BSE | - |
| 2020 |
₹6.85 Cr
$760,684 USD
|
₹22.50 | BSE | - |